It revealed that apoE23 therapy effectively reduced plasma levels of TNF-α, IL-6, and LPS; decreased bacterial load in the spleen tissue homogenate; and alleviated infection-induced lung, liver, and small intestine injuries in mice with sepsis. This evidence concerns the gene IL6 and infection.